Skip to main content

Vitamin D, Cardiovascular Disease and Risk Factors

  • Chapter
  • First Online:
Ultraviolet Light in Human Health, Diseases and Environment

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 996))

Abstract

Observational studies have suggested a possible protective role of vitamin D on the cardiovascular system. The available evidence does not support either cardiovascular benefits or harms of vitamin D supplementation. This chapter provides an overview and discussion of the current knowledge of vitamin D effects from a cardiovascular health perspective. It focuses on vitamin D in relation to cardiovascular disease, i.e. ischemic heart disease, and stroke; the traditional cardiovascular risk factors hypertension, abnormal blood lipids, obesity; and the emerging risk factors hyperparathyroidism, microalbuminuria, chronic obstructive pulmonary diseases, and non-alcoholic fatty liver disease. Meta-analyses of observational studies have largely found vitamin D levels to be inversely associated with cardiovascular risk and disease. However, Mendelian randomization studies and randomized, controlled trials (RCTs) have not been able to consistently replicate the observational findings. Several RCTs are ongoing, and the results from these are needed to clarify whether vitamin D deficiency is a causal and reversible factor to prevent cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281

    Article  CAS  PubMed  Google Scholar 

  2. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA et al (2013) A systematic review of vitamin D status in populations worldwide. Br J Nutr 9:1–23

    Google Scholar 

  3. Thuesen B, Husemoen L, Fenger M, Jakobsen J, Schwarz P, Toft U et al (2012) Determinants of vitamin D status in a general population of Danish adults. Bone 50(3):605–610

    Article  CAS  PubMed  Google Scholar 

  4. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Hannemann A, Jorgensen T et al (2015) Longitudinal associations between lifestyle and vitamin D: a general population study with repeated vitamin D measurements. Endocrine 51(2):342–350

    Article  PubMed  Google Scholar 

  5. Levy MA, McKinnon T, Barker T, Dern A, Helland T, Robertson J et al (2015) Predictors of vitamin D status in subjects that consume a vitamin D supplement. Eur J Clin Nutr 69(1):84–89

    Article  CAS  PubMed  Google Scholar 

  6. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG et al (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470

    Google Scholar 

  7. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njolstad I et al (2012) Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The tromso study. PLoS One 7(5):e37295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2012) Vitamin D status and cause-specific mortality: a general population study. PLoS One 7(12):e52423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2013) Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43(3):618–625

    Article  CAS  PubMed  Google Scholar 

  10. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035

    Article  PubMed  PubMed Central  Google Scholar 

  11. Trummer O, Pilz S, Hoffmann MM, Winkelmann BR, Boehm BO, Marz W et al (2013) Vitamin D and mortality: a Mendelian randomization study. Clin Chem 59(5):793–797

    Article  CAS  PubMed  Google Scholar 

  12. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Roswall N et al (2014) Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomark Prev 23(7):1220–1229

    Article  CAS  Google Scholar 

  13. Muldowney S, Kiely M (2010) Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 1:1–20

    Google Scholar 

  14. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294(18):2336–2341

    Article  CAS  PubMed  Google Scholar 

  15. Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ (2005) The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 28(8):1418–1423

    Article  CAS  PubMed  Google Scholar 

  16. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS (2007) 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50(1):69–77

    Article  PubMed  Google Scholar 

  17. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90(1-5):387–392

    Article  CAS  PubMed  Google Scholar 

  18. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO et al (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the ludwigshafen risk and cardiovascular health (LURIC) study. Clin Chim Acta 411(17-18):1354–1360

    Article  CAS  PubMed  Google Scholar 

  19. Zagura M, Serg M, Kampus P, Zilmer M, Eha J, Unt E et al (2011) Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg 42(5):689–695

    Article  CAS  PubMed  Google Scholar 

  20. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB (2001) 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 15(14):2751–2753

    CAS  PubMed  Google Scholar 

  21. Fassina G, Maragno I, Dorigo P, Contessa AR (1969) Effect of vitamin D2 on hormone-stimulated lipolysis in vitro. Eur J Pharmacol 5(3):286–290

    Article  CAS  PubMed  Google Scholar 

  22. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825

    CAS  PubMed  Google Scholar 

  23. Dobak J, Grzybowski J, Liu FT, Landon B, Dobke M (1994) 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J Dermatol Sci 8(1):18–24

    Article  CAS  PubMed  Google Scholar 

  24. Barchetta I, Angelico F, Del BM, Baroni MG, Pozzilli P, Morini S et al (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9:85

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al (2007) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17(7):517–524

    Article  CAS  PubMed  Google Scholar 

  26. Messenger W, Nielson CM, Li H, Beer T, Barrett-Connor E, Stone K et al (2011) Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 22(10):856–863

    Article  PubMed  PubMed Central  Google Scholar 

  27. Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170(8):1032–1039

    Article  PubMed  Google Scholar 

  29. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57(9):1595–1603

    Article  PubMed  Google Scholar 

  30. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB et al (2009) Vitamin D and mortality in older men and women. Clin Endocrinol 71(5):666–672

    Article  CAS  Google Scholar 

  31. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR et al (2010) Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64(2):203–209

    Article  CAS  PubMed  Google Scholar 

  32. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503–511

    Article  CAS  PubMed  Google Scholar 

  33. Hosseinpanah F, Yarjanli M, Sheikholeslami F, Heibatollahi M, Eskandary PS, Azizi F (2011) Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and glucose study. Atherosclerosis 218(1):238–242

    Article  CAS  PubMed  Google Scholar 

  34. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG (2012) 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 32(11):2794–2802

    Article  CAS  PubMed  Google Scholar 

  35. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903

    Article  PubMed  PubMed Central  Google Scholar 

  36. Fan H, Yu W, Cao H, Li J, Liu B, Wang J et al (2014) Meta-analysis of circulating 25-hydroxyvitamin D levels and risk of cardiovascular and all-cause mortality in elderly population. Int J Cardiol 176(3):1025–1029

    Article  PubMed  Google Scholar 

  37. Grandi NC, Breitling LP, Brenner H (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51(3-4):228–233

    Article  CAS  PubMed  Google Scholar 

  38. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K et al (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152(5):307–314

    Article  PubMed  PubMed Central  Google Scholar 

  39. Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L et al (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348:g3656

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS (2011) Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 19(4):192–201

    Article  PubMed  Google Scholar 

  41. Tomson J, Emberson J, Hill M, Gordon A, Armitage J, Shipley M et al (2013) Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J 34(18):1365–1374

    Article  CAS  PubMed  Google Scholar 

  42. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K et al (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5(6):819–829

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR et al (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 97(2):614–622

    Article  CAS  PubMed  Google Scholar 

  44. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100(3):746–755

    Article  CAS  PubMed  Google Scholar 

  45. Bolland MJ, Grey A, Gamble GD, Reid IR (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2(4):307–320

    Article  CAS  PubMed  Google Scholar 

  46. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG et al (2011) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 7:CD007470

    Google Scholar 

  47. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5):1422–1428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Khan H, Kunutsor S, Franco OH, Chowdhury R (2013) Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 72(1):89–97

    Article  CAS  PubMed  Google Scholar 

  49. Ju SY, Jeong HS (2014) Kim dH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 99(3):1053–1063

    Article  CAS  PubMed  Google Scholar 

  50. Mallika V, Goswami B, Rajappa M (2007) Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 58(5):513–522

    Article  CAS  PubMed  Google Scholar 

  51. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Fenger M et al (2012) Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 123(1):62–70

    Article  CAS  PubMed  Google Scholar 

  52. Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G (2010) High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 64(12):1457–1464

    Article  CAS  PubMed  Google Scholar 

  53. Kelishadi R, Farajzadegan Z, Bahreynian M (2014) Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr 65(4):404–410

    Article  CAS  PubMed  Google Scholar 

  54. Jorde R, Grimnes G (2011) Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50(4):303–312

    Article  CAS  PubMed  Google Scholar 

  55. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP et al (2011) Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96(7):1931–1942

    Article  CAS  PubMed  Google Scholar 

  56. Challoumas D (2014) Vitamin D supplementation and lipid profile: what does the best available evidence show? Atherosclerosis 235(1):130–139

    Article  CAS  PubMed  Google Scholar 

  57. Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16(4):341–349

    Article  CAS  PubMed  Google Scholar 

  58. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10(2):e1001383

    Article  PubMed  PubMed Central  Google Scholar 

  59. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89(3):1196–1199

    Article  CAS  PubMed  Google Scholar 

  60. Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J (2014) Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15(6):528–537

    Article  CAS  PubMed  Google Scholar 

  61. Chandler PD, Wang L, Zhang X, Sesso HD, Moorthy MV, Obi O et al (2015) Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 73(9):577–593

    Article  PubMed  PubMed Central  Google Scholar 

  62. Alexander RW (1995) Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25(2):155–161

    Article  CAS  PubMed  Google Scholar 

  63. Witham MD, Nadir MA, Struthers AD (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27(10):1948–1954

    Article  CAS  PubMed  Google Scholar 

  64. Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29(4):636–645

    Article  CAS  PubMed  Google Scholar 

  65. Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 28(3):205–221

    Article  CAS  PubMed  Google Scholar 

  66. Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C et al (2014) Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2(9):719–729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL et al (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4):779–785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25(11):1215–1222

    Article  CAS  PubMed  Google Scholar 

  69. Skaaby T, Husemoen LL, Pisinger C, Jorgensen T, Thuesen BH, Rasmussen K et al (2013) Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 44(2):473–480

    Article  CAS  PubMed  Google Scholar 

  70. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765–2771

    Article  PubMed  Google Scholar 

  71. de ZD RG, Parving HH, Keane WF, Zhang Z, Shahinfar S et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110(8):921–927

    Article  Google Scholar 

  72. O’Seaghdha CM, Hwang SJ, Holden R, Booth SL, Fox CS (2012) Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort. Am J Nephrol 36(1):68–77

    Article  PubMed  PubMed Central  Google Scholar 

  73. Joergensen C, Tarnow L, Goetze JP, Rossing P (2014) Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Diabet Med 32(3):374–381

    Article  PubMed  Google Scholar 

  74. Stone IS, Barnes NC, Petersen SE (2012) Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 98(14):1055–1062

    Article  PubMed  Google Scholar 

  75. Sin DD, Man SF (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2(1):8–11

    Article  PubMed  Google Scholar 

  76. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Fenger RV et al (2014) Vitamin d status and chronic obstructive pulmonary disease: a prospective general population study. PLoS One 9(3):e90654

    Article  PubMed  PubMed Central  Google Scholar 

  77. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C (2016) Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis of observational studies. J Hepatol 65(3):589–600

    Article  PubMed  Google Scholar 

  78. Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M et al (2012) Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 32(5):845–851

    Article  CAS  PubMed  Google Scholar 

  79. Skaaby T, Husemoen LL, Borglykke A, Jorgensen T, Thuesen BH, Pisinger C et al (2013) Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine 47(1):213–220

    Article  PubMed  Google Scholar 

  80. Skaaby T, Husemoen LL, Linneberg A (2013) Does liver damage explain the inverse association between vitamin D status and mortality? Ann Epidemiol 23(12):812–814

    Article  PubMed  Google Scholar 

  81. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040

    Article  PubMed  PubMed Central  Google Scholar 

  82. Kupferschmidt K (2012) Uncertain verdict as vitamin D goes on trial. Science 337(6101):1476–1478

    Article  PubMed  Google Scholar 

  83. Pilz S, Rutters F, Dekker JM (2012) Disease prevention: vitamin D trials. Science 338(6109):883

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tea Skaaby .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Skaaby, T., Thuesen, B.H., Linneberg, A. (2017). Vitamin D, Cardiovascular Disease and Risk Factors. In: Ahmad, S. (eds) Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology, vol 996. Springer, Cham. https://doi.org/10.1007/978-3-319-56017-5_18

Download citation

Publish with us

Policies and ethics